Cilastatin

Cilastatin
Clinical data
AHFS/Drugs.com	International Drug Names
MedlinePlus	a686013
Routes of; administration	IV
ATC code	J01DH51 (WHO) (combination with imipenem);
Identifiers
	IUPAC name (Z)-7-[(2R)-2-Amino-3-hydroxy-3-oxopropyl]sulfanyl-2-{[(1S)-2,2-dimethylcyclopropanecarbonyl]amino}hept-2-enoic acid;
CAS Number	82009-34-5 ;
PubChem CID	5280454;
IUPHAR/BPS	5166;
DrugBank	DB01597 ;
ChemSpider	4940183 ;
UNII	141A6AMN38;
KEGG	D07698 ;
ChEBI	CHEBI:3697 ;
ChEMBL	ChEMBL766 ;
CompTox Dashboard (EPA)	DTXSID8048238 ;
ECHA InfoCard	100.072.592
Chemical and physical data
Formula	C16H26N2O5S
Molar mass	358.45 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N\C(=C/CCCCSC[C@@H](C(=O)O)N)C(=O)O)[C@H]1CC1(C)C;
	InChI InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1 ; Key:DHSUYTOATWAVLW-WFVMDLQDSA-N ;
	(verify)

Cilastatin inhibits the human enzyme dehydropeptidase.^[1]